M-63

M-63

Products

Information

Bifidobacterium longum subspecies infantis M-63 is unique among gut bacteria in its immense capacity to utilize human milk oligosaccharide (HMOs), the component that is highly abundant in human breast milk. HMOs offer no direct nutritive value for infants, but they function in shaping a better infant gut microbiota with life-long impacts. M-63 possesses superior potential to colonize and adapt to the intestinal environment of humans, especially infants.
Ingredients
Microorganisms & Probiotics
Certifications
Allergen-freeHalalHealth & Safety (GMP, HACCP and Equivalents)KosherQuality Assurance
Morinaga Milk Industry Co Ltd5D80Morinaga Milk Industry is one of the largest dairy product companies in Japan. Morinaga Milk excels in innovative technology and offers various dairy products and other beneficial functional ingredients to customers around the world. Morinaga Milk started research on bifidobacteria in the 1960s, inspired by the fact that bifidobacteria are the predominant bacteria residing in the intestines of breastfed infants. In 1969, Morinaga Milk isolated its flagship strain Bifidobacterium longum BB536 from a healthy breastfed infant. Since then, Morinaga has been conducting original research to contribute to healthy, fruitful lives for all people.

Join the event!

See all the content and easy-to-use features by logging in or registering!